Antiseizure Effects of Peganum harmala L. and Lavandula angustifolia

Table 1

An overall overview of the study design.

Peganum harmala L. extract	Phase 1; (i) Assessing antiseizure activity of seven doses of P. harmala; (ii) Variables were compared between P. harmala extract in different doses and normal saline group
	Phase 2; (i) Mechanistic phase; (ii) Antiseizure activity of the most effective dose of Peganum harmala L (10 mg/kg) was compared with Peganum harmala L+ each antagonist
Lavandula angustifolia extract	Phase 1; (i) Assessing antiseizure activity in four doses of L. angustifolia; (ii) Variables were compared between L. angustifolia extract in different doses and normal saline group
	Phase 2; (i) Mechanistic phase; (ii) Antiseizure activity of the most effective dose of L. angustifolia (600 mg/kg) was compared with L. angustifolia+each antagonist